This systematic review and meta-analysis aimed to determine the short-and medium-term
weight loss outcomes and comorbidity resolution following endoscopic sleeve gastroplasty …

Background: Obesity is a chronic disease that impairs quality of life and leads to several
comorbidities. When conservative therapies fail, bariatric surgical options such as Roux-en …

Since its first description in 2013, robust evidence supporting the efficacy and safety of the
endoscopic sleeve gastroplasty (ESG) has been on the rise. A large case series and meta …

METHODS: We performed a retrospective analysis of adult patients who underwent ESG.
Medical information was abstracted from the electronic record with weight records up to 2 …

Latin America faces a significant public health challenge due to the high prevalence of
obesity and its associated diseases. Metabolic and bariatric surgery is effective and safe to …

In contrast to the “one‐size‐fits‐all” approach, precision medicine focuses on providing
health care tailored to individual variabilities. Implementing precision medicine in …

Purpose Endoscopic sleeve gastroplasty (ESG) is primarily offered to patients with class I
and II obesity (BMI 30–40), although there are no guidelines specifying applicability. There …

Obesity is a chronic, relapsing disease representing a major global health problem in the
21st century. Several etiologic factors are involved in its pathogenesis, including a Western …

Obesity is a pandemic with significant impact on the healthcare systems; endoscopic
bariatric treatments may fill the therapeutic gap between medical and surgical approaches …

This joint ASGE-ESGE guideline provides an evidence-based summary and
recommendations regarding the role of endoscopic bariatric and metabolic therapies …